Athira Pharma, Inc.
ATHA
$0.239
$0.014.37%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 51.28M | 68.86M | 91.77M | 122.09M | 147.42M |
| Total Receivables | -- | 1.63M | 1.63M | 1.63M | 1.63M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.57M | 3.15M | 4.93M | 4.92M | 5.68M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 8.37M | 8.37M | -- | -- |
| Total Current Assets | 54.84M | 82.00M | 106.70M | 128.64M | 154.73M |
|
|
|||||
| Total Current Assets | 54.84M | 82.00M | 106.70M | 128.64M | 154.73M |
| Net Property, Plant & Equipment | 3.25M | 3.56M | 3.86M | 4.14M | 4.44M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 686.00K | 686.00K | 686.00K | 686.00K | 1.08M |
| Total Assets | 58.78M | 86.25M | 111.25M | 133.46M | 160.25M |
|
|
|||||
| Total Accounts Payable | 319.00K | 388.00K | 475.00K | 681.00K | 129.00K |
| Total Accrued Expenses | 12.40M | 26.96M | 26.04M | 24.54M | 28.34M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 414.00K | 402.00K | 391.00K | 380.00K | 368.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 13.14M | 27.75M | 26.90M | 25.60M | 28.84M |
|
|
|||||
| Total Current Liabilities | 13.14M | 27.75M | 26.90M | 25.60M | 28.84M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 803.00K | 912.00K | 1.02M | 1.12M | 1.22M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 13.94M | 28.66M | 27.92M | 26.72M | 30.06M |
|
|
|||||
| Common Stock & APIC | 450.99M | 448.72M | 445.78M | 442.42M | 439.74M |
| Retained Earnings | -406.15M | -391.14M | -362.40M | -335.54M | -309.21M |
| Treasury Stock & Other | 1.00K | 3.00K | -38.00K | -137.00K | -349.00K |
| Total Common Equity | 44.84M | 57.58M | 83.34M | 106.74M | 130.19M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 44.84M | 57.58M | 83.34M | 106.74M | 130.19M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 44.84M | 57.58M | 83.34M | 106.74M | 130.19M |
|
|
|||||